Radiation for Low-Risk Prostate Cancer Becomes Less Common - Medscape
Radiation for Low-Risk Prostate Cancer Becomes Less Common Medscape
Prostate Cancer News
AstraZeneca cuts early-phase prostate cancer pipeline - Fierce Biotech
AstraZeneca cuts early-phase prostate cancer pipeline Fierce Biotech
Tumor Metabolism and the Mechanisms of Treatment Resistance in Prostate Cancer - Nima Sharifi - UroToday
Tumor Metabolism and the Mechanisms of Treatment Resistance in Prostate Cancer - Nima Sharifi UroToday
Scientists hope to double leukaemia survival rates with new trial method - The Telegraph
Scientists hope to double leukaemia survival rates with new trial method The Telegraph
Comparative Cost-Effectiveness of Prostate-Specific Membrane Antigen Positron Emission Tomography Agents and Conventional Imaging for Initial Diagnosis of Prostate Cancer in the United States - Cureus
Comparative Cost-Effectiveness of Prostate-Specific Membrane Antigen Positron Emission Tomography Agents and Conventional Imaging for Initial Diagnosis of Prostate Cancer in the United States Cureus
Rambachan urges men to get prostate cancer screening - Trinidad Guardian
Rambachan urges men to get prostate cancer screening Trinidad Guardian
49ers' George Kittle Shares How Emotional Family History of Cancer Changed Him - Yahoo Sports
49ers' George Kittle Shares How Emotional Family History of Cancer Changed Him Yahoo Sports
I'm A Celeb & CBB star Wayne Sleep reveals cancer diagnosis & shares update - The Sun
I'm A Celeb & CBB star Wayne Sleep reveals cancer diagnosis & shares update The Sun
Tailoring prostate cancer radiotherapy to body clock could cut long-term side effects - News-Medical
Tailoring prostate cancer radiotherapy to body clock could cut long-term side effects News-Medical
Kudos: Richmond senior men's golf club raise another $68K for prostate cancer research - Richmond News
Kudos: Richmond senior men's golf club raise another $68K for prostate cancer research Richmond News
Diagnostic test could flag which men need aggressive prostate cancer treatment and which don't - Fox News
Diagnostic test could flag which men need aggressive prostate cancer treatment and which don't Fox News
Blood mRNA Model Predicts Castration Resistance in Metastatic Prostate Cancer - CancerNetwork
Blood mRNA Model Predicts Castration Resistance in Metastatic Prostate Cancer CancerNetwork
Factors shaping PSMA-PET agent selection in prostate cancer - Urology Times
Factors shaping PSMA-PET agent selection in prostate cancer Urology Times
ASTRO Updates Guideline on Shorter-Course Radiation Therapy for Localized Prostate Cancer - The ASCO Post
ASTRO Updates Guideline on Shorter-Course Radiation Therapy for Localized Prostate Cancer The ASCO Post
The molecular heterogeneity and clinical impact of genomic driver alterations in prostate cancer - Nature
The molecular heterogeneity and clinical impact of genomic driver alterations in prostate cancer Nature
Life After a Prostate Cancer Diagnosis: Why It’s a Pivot, Not an Ending - Cure Today
Life After a Prostate Cancer Diagnosis: Why It’s a Pivot, Not an Ending Cure Today
Prostate Cancer - Focused Ultrasound Foundation
Prostate Cancer Focused Ultrasound Foundation
Should Nubeqa Join ADT + Radiation in Very-High-Risk Localized Prostate Cancer? - OncologyTube - Oncodaily
Should Nubeqa Join ADT + Radiation in Very-High-Risk Localized Prostate Cancer? - OncologyTube Oncodaily
Prostate Cancer Drug Shows Promise in New Clinical Trial - Yale School of Medicine
Prostate Cancer Drug Shows Promise in New Clinical Trial Yale School of Medicine
ASTRO Guideline Backs Hypofractionation Across Risk Groups in Localized Prostate Cancer - OncLive
ASTRO Guideline Backs Hypofractionation Across Risk Groups in Localized Prostate Cancer OncLive
Beards & Blue Ribbons takes aim at prostate cancer - The Arkansas Democrat-Gazette
Beards & Blue Ribbons takes aim at prostate cancer The Arkansas Democrat-Gazette
Darolutamide Improves Metastasis-Free Survival in Very High Risk Localized Prostate Cancer - Oncology News Central
Darolutamide Improves Metastasis-Free Survival in Very High Risk Localized Prostate Cancer Oncology News Central
New ASTRO Guideline Backs Hypofractionated Radiation in Prostate Cancer - CancerNetwork
New ASTRO Guideline Backs Hypofractionated Radiation in Prostate Cancer CancerNetwork
Defining and Staging Very High-Risk Localized Prostate Cancer - Urology Times
Defining and Staging Very High-Risk Localized Prostate Cancer Urology Times
Why PSA Monitoring Matters After a Prostate Cancer Diagnosis - Cure Today
Why PSA Monitoring Matters After a Prostate Cancer Diagnosis Cure Today
Alicia Morgans, MD, MPH, highlights key prostate cancer data from ESMO 2026 - Urology Times
Alicia Morgans, MD, MPH, highlights key prostate cancer data from ESMO 2026 Urology Times
New Study Identifies Biological Mechanism Driving Therapy Resistance in Advanced Prostate Cancer | Newswise - Newswise
New Study Identifies Biological Mechanism Driving Therapy Resistance in Advanced Prostate Cancer | Newswise Newswise
Discovery of new bacteria opens fresh avenues for prostate cancer research - News-Medical
Discovery of new bacteria opens fresh avenues for prostate cancer research News-Medical
When PSMA PET Is Not Enough in Prostate Cancer Imaging - Andrei Iagaru - UroToday
When PSMA PET Is Not Enough in Prostate Cancer Imaging - Andrei Iagaru UroToday
Genomic Classification and Survival in Metastatic Hormone-Sensitive Prostate Cancer Among Veterans - Martin Schoen - UroToday
Genomic Classification and Survival in Metastatic Hormone-Sensitive Prostate Cancer Among Veterans - Martin Schoen UroToday
Rare prostate cancer histologies: detection, characteristics and treatment - Nature
Rare prostate cancer histologies: detection, characteristics and treatment Nature
Salomon Izere: Mapping Diagnostic Delays in Prostate Cancer Care in Rwanda - Oncodaily
Salomon Izere: Mapping Diagnostic Delays in Prostate Cancer Care in Rwanda Oncodaily
Darolutamide Ups Metastasis-Free Survival in Prostate Cancer - Medscape
Darolutamide Ups Metastasis-Free Survival in Prostate Cancer Medscape
49ers TE George Kittle Teams Up With Novartis For Prostate Cancer Awareness - Sports Illustrated
49ers TE George Kittle Teams Up With Novartis For Prostate Cancer Awareness Sports Illustrated
Johnson & Johnson's prostate cancer drug shrinks tumors in early-stage trial - Reuters
Johnson & Johnson's prostate cancer drug shrinks tumors in early-stage trial Reuters
FDA Expands Talazoparib Combo Indication in Prostate Cancer - Medscape
FDA Expands Talazoparib Combo Indication in Prostate Cancer Medscape
The OncFive: Top Oncology Articles for the Week of 10/25 - OncLive
The OncFive: Top Oncology Articles for the Week of 10/25 OncLive
'Well, it's prostate cancer': George Kittle opens up about cancer's impact on his family and how the expe - The Times of India
'Well, it's prostate cancer': George Kittle opens up about cancer's impact on his family and how the expe The Times of India
Pfizer’s Talzenna combo moves up treatment line with new FDA nod in prostate cancer - Fierce Pharma
Pfizer’s Talzenna combo moves up treatment line with new FDA nod in prostate cancer Fierce Pharma
JNJ-6143 Elicits PSA Responses in Heavily Pretreated mCRPC - Targeted Oncology
JNJ-6143 Elicits PSA Responses in Heavily Pretreated mCRPC Targeted Oncology